These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2855073)

  • 1. Device for intracellular increase of oxygen free radicals and inhibition of MethA tumour cell proliferation: in vitro and in vivo studies.
    Mashiba H; Matsunaga K
    Int J Tissue React; 1988; 10(5):273-80. PubMed ID: 2855073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented inhibition of tumor cell proliferation in the combined use of disulfiram with ascorbic acid and the involvement of oxygen free radicals.
    Mashiba H; Matsunaga K
    Jpn J Exp Med; 1990 Aug; 60(4):209-14. PubMed ID: 2292808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented antiproliferative effect of tumor necrosis factor (TNF), lymphotoxin and glycyrrhizin in combined use with diethyldithiocarbamate on Meth A tumor cells in vitro.
    Mashiba H; Matsunaga K
    Jpn J Exp Med; 1990 Apr; 60(2):67-71. PubMed ID: 2166841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented inhibition of MethA tumor cell proliferation in combined use of diethyldithiocarbamate with catalase or by a nondialysable fraction from co-incubation.
    Mashiba H; Matsunaga K
    Toxicol Lett; 1993 Jan; 66(1):97-104. PubMed ID: 8381244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotargeting approach utilizing production of oxygen free radicals.
    Mashiba H; Matsunaga K
    Cancer Lett; 1990 Dec; 55(3):183-8. PubMed ID: 2175248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attempt to augment the anti-proliferative effect of recombinant human lymphotoxin in combined use with anti-tumor antibody-diethyldithiocarbamate conjugates.
    Mashiba H; Matsunaga K
    Eur Cytokine Netw; 1991; 2(3):195-9. PubMed ID: 1654145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo radiosensitization by diethyldithiocarbamate.
    Kent CR; Blekkenhorst GH
    Radiat Res; 1988 Dec; 116(3):539-46. PubMed ID: 2849781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset and growth rate of solid tumours derived from implanted ascites tumour cells pretreated with ascorbic acid.
    Liotti FS; Locci P
    Boll Ist Sieroter Milan; 1986; 65(1):61-4. PubMed ID: 3718681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of radiosensitizing effect of the nitroimidazole derivative RK28 on the proliferation of MethA tumor cells in combined use with diethyldithiocarbamate.
    Mashiba H; Matsunaga K; Hata K
    Life Sci; 1991; 49(19):1419-25. PubMed ID: 1658511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid and glucose oxidation by ultraviolet A-generated oxygen free radicals.
    Giangiacomo A; Olesen PR; Ortwerth BJ
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1549-56. PubMed ID: 8675397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithinized ascorbic acid (PC-AS) effectively inhibits murine pulmonary metastasis.
    Takenaga M; Igarashi R; Nakayama T; Mizushima Y
    Anticancer Res; 1999; 19(2A):1085-91. PubMed ID: 10368658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal cell morphology and cytotoxic effect are induced by 6-0-palmitol-ascorbate-2-0-phosphate, but not by ascorbic acid or hyperthermia alone.
    Kageyama K; Yamada R; Otani S; Hasuma T; Yoshimata T; Seto C; Takada Y; Yamaguchi Y; Kogawa H; Miwa N
    Anticancer Res; 1999; 19(5B):4321-5. PubMed ID: 10628394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis.
    Menon M; Maramag C; Malhotra RK; Seethalakshmi L
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):17-30. PubMed ID: 9923964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
    Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diethyldithiocarbamate inhibits in vivo Cu,Zn-superoxide dismutase and perturbs free radical processes in the yeast Saccharomyces cerevisiae cells.
    Lushchak V; Semchyshyn H; Lushchak O; Mandryk S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1739-44. PubMed ID: 16274662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase.
    Freeman BA; Turrens JF; Mirza Z; Crapo JD; Young SL
    Fed Proc; 1985 Jul; 44(10):2591-5. PubMed ID: 4007180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.